Stay updated on BMS-986205 Combo with Nivolumab in Chinese Patients Clinical Trial

Sign up to get notified when there's something new on the BMS-986205 Combo with Nivolumab in Chinese Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BMS-986205 Combo with Nivolumab in Chinese Patients Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.3.4 appears on the page, replacing the previous v3.3.3; this reflects a minor metadata update with no visible changes to study content. No edits to core sections such as study results, eligibility criteria, or endpoints are detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:33:13.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added a Locations section with Zhejiang as a location (Hangzhou, Zhejiang, China, 310016) and updated the page revision to v3.3.3. The prior Zhejiang Locations entry and the HHS Vulnerability Disclosure were removed.
    Difference
    0.2%
    Check dated 2025-12-23T10:14:52.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Minor revision bump from v3.3.1 to v3.3.2 with no observable content or layout changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:25:29.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page shows a new revision entry (v3.3.1) and removal of the previous revision (v3.2.0) in the revision history. This is a metadata update and does not affect the study details or user-facing content.
    Difference
    0.1%
    Check dated 2025-11-24T14:34:03.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The funding-status notice has been removed from the page, which is an administrative display change and does not affect core trial content such as eligibility, endpoints, or locations.
    Difference
    0.4%
    Check dated 2025-11-17T06:48:35.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Minor editorial and formatting adjustments observed; core study details, outcomes, and eligibility criteria appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:14:09.000Z thumbnail image

Stay in the know with updates to BMS-986205 Combo with Nivolumab in Chinese Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BMS-986205 Combo with Nivolumab in Chinese Patients Clinical Trial page.